학술논문
P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 747-748 (2022)
Subject
Language
English
ISSN
2572-9241